SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-076987
Filing Date
2024-07-01
Accepted
2024-07-01 19:17:33
Documents
1
Period of Report
2024-07-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2418517-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2418517-3_4seq1.xml 4 4025
  Complete submission text file 0001104659-24-076987.txt   5667
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Scadden David (Reporting) CIK: 0001707715 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36296 | Film No.: 241092394